أعرض في EDS

P-58 Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: A multi-centric, multi-national, prospective, longitudinal, non-interventional study in Germany and Austria – BERING CRC

التفاصيل البيبلوغرافية
العنوان: P-58 Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: A multi-centric, multi-national, prospective, longitudinal, non-interventional study in Germany and Austria – BERING CRC
المؤلفون: Armin Gerger, Arndt Vogel, Sebastian Stintzing, B. Krammer-Steiner, S. Hegewisch-Becker, G. Hübner, B. Schmidt, Manfred Welslau, F. Reichenbach, J. Schröder, Thomas Winder, Gerald W. Prager, D. Bürkle, Thomas Göhler, H. Müller-Huesmann, Dirk Arnold, E. von der Heyde, J. Kisro
المصدر: Annals of Oncology. 32:S116
بيانات النشر: Elsevier BV, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cetuximab, Colorectal cancer, business.industry, Hematology, medicine.disease, BRAF V600E, Multi national, Internal medicine, Encorafenib, Non interventional, medicine, In patient, business, medicine.drug
تدمد: 0923-7534
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d05005d25f500c3fdb57e49ba2e4dedb
https://doi.org/10.1016/j.annonc.2021.05.113
حقوق: OPEN
رقم الأكسشن: edsair.doi...........d05005d25f500c3fdb57e49ba2e4dedb
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534